Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study.
AIM: To show that vildagliptin added to metformin is non-inferior to glimepiride in reducing HbA1c levels from baseline over 2 years. METHODS: A randomized, double-blind, active-comparator study of patients with type 2 diabetes mellitus inadequately controlled (HbA1c 6.5-8.5%) by metformin monother...
Main Authors: | Matthews, DR, Dejager, S, Ahren, B, Fonseca, V, Ferrannini, E, Couturier, A, Foley, J, Zinman, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Changes in prandial glucagon levels after 2 years treatment with vildagliptin or glimepiride
by: Ahren, B, et al.
Published: (2009) -
Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy.
by: Ahrén, B, et al.
Published: (2010) -
Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy.
by: Ferrannini, E, et al.
Published: (2009) -
Comparison of safety and efficacy of glimepiride-metformin and vildagliptin- metformin treatment in newly diagnosed type 2 diabetic patients
by: Surendra Kumar
Published: (2021-01-01) -
Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.
by: Hermansen, K, et al.
Published: (2010)